结直肠癌腹膜种植转移的相关因素分析

何振华 张森 宋现青 吴振杰 欧阳君 张薛磊

何振华, 张森, 宋现青, 吴振杰, 欧阳君, 张薛磊. 结直肠癌腹膜种植转移的相关因素分析[J]. 中国肿瘤临床, 2013, 40(2): 107-110. doi: 10.3969/j.issn.1000-8179.2013.02.012
引用本文: 何振华, 张森, 宋现青, 吴振杰, 欧阳君, 张薛磊. 结直肠癌腹膜种植转移的相关因素分析[J]. 中国肿瘤临床, 2013, 40(2): 107-110. doi: 10.3969/j.issn.1000-8179.2013.02.012
Zhenhua HE, Sen ZHANG, Xianqing SONG, Zhenjie WU, Jun OUYANG, Xuelei ZHANG. Related factors of peritoneal metastasis in colorectal cancer[J]. CHINESE JOURNAL OF CLINICAL ONCOLOGY, 2013, 40(2): 107-110. doi: 10.3969/j.issn.1000-8179.2013.02.012
Citation: Zhenhua HE, Sen ZHANG, Xianqing SONG, Zhenjie WU, Jun OUYANG, Xuelei ZHANG. Related factors of peritoneal metastasis in colorectal cancer[J]. CHINESE JOURNAL OF CLINICAL ONCOLOGY, 2013, 40(2): 107-110. doi: 10.3969/j.issn.1000-8179.2013.02.012

结直肠癌腹膜种植转移的相关因素分析

doi: 10.3969/j.issn.1000-8179.2013.02.012
基金项目: 

国家自然科学基金 81160235

国家自然科学基金 30672059

广西研究生教育创新计划项目 2011105981002M208

详细信息
    通讯作者:

    张森  zs0771@hotmail.com

Related factors of peritoneal metastasis in colorectal cancer

Funds: 

National Natural Science Foundation of China 81160235

National Natural Science Foundation of China 30672059

Innovation Project of Guangxi Graduate Education 2011105981002M208

More Information
  • 摘要:   目的   探讨影响结直肠癌腹膜种植转移的临床病理相关因素。   方法   收集2005年1月至2009年12月广西医科大学第一附属医院的结直肠癌患者1 170例的临床病理资料, 研究结直肠癌腹膜种植转移与临床病理因素的关系。采用非条件Logistic回归单因素分析, 并对有统计学意义的变量进行非条件Logistic回归多因素分析。   结果   1 170例结直肠癌患者中, 腹膜种植转移92例(7.86%)。单因素分析显示, 患者的年龄、肿瘤部位、浸润肠腔周径、肿瘤最大径、组织病理学类型、分化程度、肠壁浸润深度、淋巴结转移和血CEA水平与结直肠癌腹膜转移有关。Logistic多因素分析显示, 肿瘤部位、浸润肠腔周径、分化程度、肠壁浸润深度、淋巴结转移和血CEA水平与结直肠癌腹膜转移的有关。   结论   肿瘤部位、浸润肠腔周径、分化程度、肠壁浸润深度、淋巴结转移和血CEA水平是结直肠癌发生腹膜转移的独立相关因素。

     

  • 表  1  1170例结直肠癌腹膜转移患者的临床病理特征单因素分析

    Table  1.   Logistic univariate regression analysis of peritoneal metastasis in 1170 colorectal cancer cases

    表  2  1 170例结直肠癌腹膜转移患者的临床病理特征多因素分析

    Table  2.   Logistic multivariate regression analysis of peritoneal metastasis in 1 170 colorectal cancer cases

  • [1] Jemal A, Bray F, Center MM, et al. Global cancer statistics[J]. CACancer J Clin, 2011, 61(2): 69-90. doi: 10.3322/caac.20107
    [2] Cunningham D, Atkin W, Lenz HJ, et al. Colorectal cancer[J]. Lancet, 2010, 375(9719): 1030-1047. doi: 10.1016/S0140-6736(10)60353-4
    [3] Koppe MJ, Boerman OC, Oyen WJ, et al. Peritoneal carcinomatosis of colorectal origin: incidence and current treatment strategies[J]. Ann Surg, 2006, 243(2): 212-222. doi: 10.1097/01.sla.0000197702.46394.16
    [4] Segelman J, Granath F, Holm T, et al. Incidence, prevalence andrisk factors for peritoneal carcinomatosis from colorectal cancer[J]. Br J Surg, 2012, 99(5): 699-705. doi: 10.1002/bjs.8679
    [5] Jayne DG, Fook S, Loi C, et al. Peritoneal carcinomatosis fromcolorectal cancer[J]. Br J Surg, 2002, 89(12): 1545-1550. doi: 10.1046/j.1365-2168.2002.02274.x
    [6] 晏仲舒. 对待腹膜肿瘤种植转移的新概念[J]. 中国普通外科杂志, 2006, 15(10): 801-802. doi: 10.3969/j.issn.1005-6947.2006.10.021
    [7] Gomez-Portilla A, Cendoya I, Lopez de Tejada I, et al. Principlesof the treatment of peritoneal carcinomatosis due to colorectal cancer. Current review and update[J]. Cir Esp, 2005, 77(1): 6-17. doi: 10.1016/S0009-739X(05)70796-X
    [8] Lemmens VE, Klaver YL, Verwaal VJ, et al. Predictors and survival of synchronous peritoneal carcinomatosis of colorectal origin: apopulation-based study[J]. Int J Cancer, 2011, 128(11): 2717-2725. doi: 10.1002/ijc.25596
    [9] 刘峰, 余江, 梁耀泽, 等. 结直肠癌腹膜种植转移的危险因素分析[J]. 中华胃肠外科杂志, 2011, 14(4): 254-256. doi: 10.3760/cma.j.issn.1671-0274.2011.04.007
    [10] 宋武, 何裕隆, 蔡世荣, 等. 结直肠癌伴腹膜扩散的临床病理分析及手术干预对预后的影响[J]. 中华外科杂志, 2008, 46(21): 1634-1637. doi: 10.3321/j.issn:0529-5815.2008.21.011
    [11] Sjo OH, Berg M, Merok MA, et al. Peritoneal carcinomatosis of colon cancer origin: highest incidence in women and in patients withright-sided tumors[J]. J Surg Oncol, 2011, 104(7): 792-797. doi: 10.1002/jso.21959
    [12] Glebov OK, Rodriguez LM, Nakahara K, et al. Distinguishing rightfrom left colon by the pattern of gene expression[J]. Cancer Epidemiol Biomarkers Prev, 2003, 12(8): 755-762.
    [13] Meguid RA, Slidell MB, Wolfgang CL, et al. Is there a difference insurvival between right-versus left-sided colon cancers[J]AnnSurg Oncol, 2008, 15(9): 2388-2394.
    [14] Raftopoulos I, Davaris P, Karatzas G, et al. Level of alpha-cateninexpression in colorectal cancer correlates with invasiveness, metastatic potential, and survival[J]. J Surg Oncol, 1998, 68(2): 92-99. doi: 10.1002/(SICI)1096-9098(199806)68:2<92::AID-JSO4>3.0.CO;2-F
    [15] Filiz AI, Senol Z, Sucullu I, et al. The survival effect of E-cadherinand catenins in colorectal carcinomas[J]. Colorectal Dis, 2010, 12(12): 1223-1230. doi: 10.1111/j.1463-1318.2009.01994.x
    [16] Aresu L, Pregel P, Zanetti R, et al. E-cadherin and beta-catenin expression in canine colorectal adenocarcinoma[J]. Res Vet Sci, 2010, 89(3): 409-414. doi: 10.1016/j.rvsc.2010.04.008
    [17] Ceelen WP, Bracke ME. Peritoneal minimal residual disease incolorectal cancer: mechanisms, prevention, and treatment[J]. LancetOncol, 2009, 10(1): 72-79.
    [18] Matsuda K, Hotta T, Takifuji K, et al. Lymph nodes ratio is associated with the survival of colorectal cancer patients with peritonealcarcinomatosis[J]. Am Surg, 2011, 77(5): 602-607. doi: 10.1177/000313481107700521
    [19] Chua TC, Yan TD, Ng KM, et al. Significance of lymph node metastasis in patients with colorectal cancer peritoneal carcinomatosis[J]. World J Surg, 2009, 33(7): 1488-1494. doi: 10.1007/s00268-009-0059-6
    [20] Reeder JA, Gotley DC, Walsh MD, et al. Expression of antisenseCD44 variant 6 inhibits colorectal tumor metastasis and tumorgrowth in a wound environment[J]. Cancer Res, 1998, 58(16): 3719-3726.
    [21] 荆结线, 杜丽莉, 王文达, 等. 结直肠癌患者血清肿瘤标志物水平与临床病理学特征的关系[J]. 中国肿瘤临床, 2008, 35(3): 162-166. doi: 10.3969/j.issn.1000-8179.2008.03.013
  • 加载中
表(2)
计量
  • 文章访问数:  25
  • HTML全文浏览量:  7
  • PDF下载量:  6
  • 被引次数: 0
出版历程
  • 收稿日期:  2012-05-26
  • 修回日期:  2012-09-05

目录

    /

    返回文章
    返回